📰 Stagezero Life Sciences News
Page 3 - Stagezero Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stagezero Life Sciences. Real-time updates on events, politics, business and more.
April 29, 2023
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) saw a significant decline in short interest in April. As of April 15th, there was short interest totalling 9,000 shares, a decline of 69.9% from the March 31st total of 29,900 shares. Based on an average daily volume of 8,000 shares, the days-to-cover ratio is currently 1.1 […]
April 9, 2023
Lucira Health (NASDAQ:LHDXQ – Get Rating) and StageZero Life Sciences (OTCMKTS:SZLSF – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Institutional & Insider Ownership 57.0% of Lucira Health […]
April 1, 2023
Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection
March 30, 2023
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational
March 30, 2023
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational
March 29, 2023
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, the short-interest ratio […]
March 29, 2023
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, […]
February 24, 2023
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 publicly-traded companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Valuation & […]
February 7, 2023
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 public companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to similar businesses based on the strength of its dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Valuation and […]
February 2, 2023
Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving